Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan ― Results From Post-Marketing Surveillance (XASSENT) ―Ikuo Fukuda, Takanori Hayasaki, Hideaki Maeda et al.|Circulation Journal|2023Cited by 3
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)Ikuo Fukuda, Takanori Hayasaki, Atsushi Hirayama et al.|TH Open|2021Cited by 2